BridgeBio Pharma and LianBio Announce First Patient Treated in Phase 2a Trial of Infigratinib

August 25, 2021– Palo Alto, California & Shanghai & Princeton, New Jersey (Business Wire) — LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major Asian markets, and BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced the first patient has been treated in a Phase 2a clinical trial of infigratinib in patients with locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with fibroblast growth factor receptor-2 (FGFR2) gene amplification and other advanced solid tumors with FGFR genomic alterations.

“We believe that infigratinib could have a meaningful impact for people living with gastric cancer as well as many other cancers with FGFR alterations, and are pleased LianBio is initiating this clinical trial in China where more therapeutic options are needed to match the growing diagnosis rate.”

“Infigratinib is a potent and selective FGFR inhibitor that has demonstrated compelling clinical activity across multiple tumor types with FGFR alterations,” said Yizhe Wang, Ph.D., chief executive officer of LianBio. “Given the disproportionately high prevalence rate of gastric cancer in China, LianBio is pursuing a region-specific development strategy focused on this area of great unmet need. This study marks LianBio’s first trial initiation and demonstrates our continued progress in delivering potentially transformational medicines to patients in Asia.” Continue reading

Orange and Google Cloud to form strategic partnership

PARIS, July 28, 2020 /PRNewswire/ — Orange and Google Cloud today announced a strategic partnership to accelerate the transformation of Orange’s IT infrastructure and the development of future cloud services, in particular edge computing. The agreement reinforces Orange’s commitment, as set out in its Engage 2025 plan, to drive its internal transformation through the innovative and widespread use of artificial intelligence (AI) and data in order to improve operational efficiency and the customer experience. The collaboration will also pave the way for the development of new advanced cloud, edge computing and cybersecurity services that will open up business opportunities for both Google Cloud and Orange. Continue reading

Zenoss Now Available on Google Cloud Marketplace

AUSTIN, TexasJuly 28, 2020 /PRNewswire/ — Zenoss Inc., a leader in intelligent application and service monitoring, today announced a new offering on the Google Cloud  Marketplace, making it easier for organizations to immediately access and leverage Zenoss monitoring and AIOps. As a subscription-based offering, Zenoss Cloud delivers full-stack monitoring combined with the power of AIOps, enabling holistic intelligent application and service monitoring with a goal of lights-out IT operations. Continue reading